Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novanta | NOVT | Nov 22, 2024 | 169.79 | +3.08 |
Novartis ADR | NVS | Nov 22, 2024 | 104.28 | +0.41 |
Novavax | NVAX | Nov 22, 2024 | 8.47 | +5.35 |
Novo Integrated Sciences | NVOS | Nov 22, 2024 | 0.17 | 0.00 |
Novo Nordisk ADR | NVO | Nov 22, 2024 | 105.06 | +2.37 |
NovoCure | NVCR | Nov 22, 2024 | 17.73 | +3.74 |
Novonix ADR | NVX | Nov 22, 2024 | 1.93 | +0.52 |
NRG Energy | NRG | Nov 22, 2024 | 95.48 | -1.46 |
NRx Pharmaceuticals | NRXP | Nov 22, 2024 | 1.26 | +2.44 |
NSTS Bancorp | NSTS | Nov 22, 2024 | 11.24 | +0.45 |
Nu Holdings | NU | Nov 22, 2024 | 13.91 | +3.81 |
Nu Skin Enterprises | NUS | Nov 22, 2024 | 7.22 | -1.10 |
Nuburu | BURU | Nov 22, 2024 | 0.47 | +2.50 |
NuCana ADR | NCNA | Nov 22, 2024 | 1.23 | -3.15 |
Nucor | NUE | Nov 22, 2024 | 151.92 | +1.29 |
Nukkleus | NUKK | Nov 22, 2024 | 1.75 | -2.78 |
Nurix Therapeutics | NRIX | Nov 22, 2024 | 22.05 | -1.43 |
NuScale Power | SMR | Nov 22, 2024 | 30.21 | +9.18 |
Nustar Energy C Pref | NS-C | Nov 22, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Nov 22, 2024 | 73.18 | +3.16 |
Nutex Health | NUTX | Nov 22, 2024 | 32.91 | +3.20 |
Nutriband | NTRB | Nov 22, 2024 | 4.81 | -2.63 |
Nutrien | NTR | Nov 22, 2024 | 46.93 | +0.13 |
Nuvalent A | NUVL | Nov 22, 2024 | 94.93 | +2.37 |
Nuvation Bio A | NUVB | Nov 22, 2024 | 2.80 | +3.70 |
Nuvectis Pharma | NVCT | Nov 22, 2024 | 5.10 | +4.08 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Nov 22, 2024 | 12.89 | +1.18 |
Nuveen Amtfree Municipal Value Fund | NUW | Nov 22, 2024 | 13.84 | -0.18 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | Nov 22, 2024 | 11.62 | +0.17 |
Nuveen Arizona Quality Municipal Fund | NAZ | Nov 22, 2024 | 12.25 | +1.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.